Clover Biopharmaceuticals, Ltd announced that it will receive $320,713 in funding on April 2, 2024. The company will issue common shares in the transaction. The company will issue securities pursuant to exemption provided under Regulation D.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.47 HKD | +5.62% | +20.51% | -24.19% |
12/04 | Clover Biopharmaceuticals, Ltd. announced that it has received $0.320713 million in funding | CI |
08/04 | Clover Biopharmaceuticals' RSV Vaccine Candidate Shows Promise in Early Trial | MT |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-24.19% | 73.9M | |
+7.72% | 113B | |
+10.92% | 106B | |
+0.41% | 22.27B | |
-11.88% | 22.22B | |
-5.99% | 19.43B | |
-37.36% | 17.87B | |
-5.58% | 17.24B | |
+6.75% | 14.29B | |
+35.69% | 12.52B |
- Stock Market
- Equities
- 2197 Stock
- News Clover Biopharmaceuticals, Ltd.
- Clover Biopharmaceuticals, Ltd. announced that it expects to receive $0.320713 million in funding